Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.64 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.64 |
| ▸ | APP | P05067 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | G6PD | P11413 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maritimein SCHEMBL29354648 | 1.00 | MEN1 (1.00) | MEN1KMT2ACDK5CDK5R1APP | |
| Maritimein SCHEMBL1706306 | 1.00 | MEN1 (1.00) | MEN1KMT2ACDK5CDK5R1APP | |
| SCHEMBL31360843 | 0.89 | MEN1 (0.81) | MEN1KMT2ACDK5CDK5R1APP | |
| SCHEMBL1098173 | 0.89 | MEN1 (0.81) | MEN1KMT2ACDK5CDK5R1APP | |
| Maritimein SCHEMBL7203694 | 0.85 | MEN1 (0.73) | MEN1KMT2ACDK5CDK5R1TDP1 | |
| SCHEMBL12405921 | 0.83 | MEN1 (0.71) | MEN1KMT2AGAATDP1PTPN1 | |
| Sulfurein SCHEMBL29462894 | 0.83 | CDK5 (0.77) | MEN1KMT2ACDK5CDK5R1GAA | |
| Sulfurein SCHEMBL2817568 | 0.83 | CDK5 (0.77) | MEN1KMT2ACDK5CDK5R1GAA | |
| SCHEMBL1043781 | 0.80 | CDK5 (0.80) | MEN1KMT2ACDK5CDK5R1GAA | |
| SCHEMBL13324395 | 0.79 | MEN1 (0.66) | MEN1KMT2ACDK5CDK5R1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11712056-B2 | Extract obtained from several plants for use in the prevention and/or treatment of chronic inflammatory bowel diseases | VALBIOTIS (FR) | 2023-08-01 | — | — | US | claimed |
| EP-3982924-B1 | PLANT EXTRACT MIXTURE FOR USE IN THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY BOWEL DISEASES | VALBIOTIS (FR) | 2023-07-26 | — | — | EP | claimed |
| US-20220257685-A1 | PLANT EXTRACT MIXTURE FOR USE IN THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY BOWEL DISEASES | VALBIOTIS (FR) | 2022-08-18 | — | — | US | claimed |
| EP-4039332-A1 | METHOD OF EXTRACTION AND ENRICHMENT OF MONOGLYCOSYLATED FLAVONOIDS FROM CHRYSANTHELLUM INDICUM FOR THE TREATMENT OF INFLAMMATORY-BASED POLYARTHRITIC DISORDERS, FOR USE IN COSMETIC, NUTRACEUTICAL AND MEDICAL DEVICES AND PHARMACEUTICAL APPLICATIONS | Phytoitalia SRL (IT) | 2022-08-10 | — | — | EP | claimed |
| EP-3533454-B1 | COMPOSITION COMPRISING A MIXTURE OF PLANT EXTRACTS OR A MIXTURE OF MOLECULES CONTAINED IN SAID PLANTS AND USE TO ACT ON THE CARBOHYDRATE AND/OR LIPID METABOLISM | VALBIOTIS (FR) | 2022-04-20 | — | — | EP | claimed |
| EP-3982924-A1 | PLANT EXTRACT MIXTURE FOR USE IN THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY BOWEL DISEASES | Valbiotis (FR) | 2022-04-20 | — | — | EP | claimed |
| US-20200359670-A1 | EXTRACT OBTAINED FROM SEVERAL PLANTS FOR USE IN THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY BOWEL DISEASES | UNIVERSITE CLERMONT AUVERGNE (FR) | 2020-11-19 | — | — | US | claimed |
| US-10736930-B2 | Compositions and methods for controlling carbohydrate and fat metabolism | VALBIOTIS (FR) | 2020-08-11 | — | — | US | claimed |
| EP-3332793-B1 | COMPOSITION COMPRISING A MIXTURE OF PLANT EXTRACTS OR A MIXTURE OF MOLECULES CONTAINED IN SAID PLANTS AND USE TO ACT ON THE CARBOHYDRATE AND/OR LIPID METABOLISM | VALBIOTIS (FR) | 2020-03-18 | — | — | EP | claimed |
| EP-3209315-B1 | COMPOSITION CONTAINING A MIXTURE OF PLANT EXTRACTS OR A MIXTURE OF MOLECULES CONTAINED IN SAID PLANTS, AND USE FOR CONTROLLING GLUCIDE AND/OR LIPID METABOLISM | VALBIOTIS (FR) | 2019-04-24 | — | — | EP | claimed |
| US-20160106793-A1 | COMPOSITIONS AND METHODS FOR CONTROLING CARBOHYDRATE AND FAT METABOLISM | UNIVERSITE CLERMONT AUVERGNE (FR) | 2016-04-21 | — | — | US | claimed |
| US-20140088030-A1 | WATER SOLUBLE AND ACTIVABLE PHENOLICS DERIVATIVES WITH DERMOCOSMETIC AND THERAPEUTIC APPLICATIONS AND PROCESS FOR PREPARING SAID DERIVATIVES | LIBRAGEN (FR) | 2014-03-27 | — | — | US | claimed |
| EP-2027279-B1 | Phenolic compounds with cosmetic and therapeutic applications | LIBRAGEN (FR) | 2012-04-18 | — | — | EP | claimed |
| EP-2379576-A1 | HYDROSOLUBLE [6)-O-alpha-D-GLCP-(1->]n-6-O-beta-D-GLCP-(1->-PHENOLIC DERIVATIVES WITH DERMOCOSMETIC, NUTRITIONAL AND THERAPEUTIC APPLICATIONS, AND COMPOSITIONS CONTAINING SAID WATER SOLUBLE COMPOUNDS | Libragen (FR) | 2011-10-26 | — | — | EP | claimed |
| WO-2010072754-A1 | HYDROSOLUBLE [6)O-α-D-GLCP-(1→]n-6-O-β-D-GLCP-(1→-PHENOLIC DERIVATIVES WITH DERMOCOSMETIC, NUTRITIONAL AND THERAPEUTIC APPLICATIONS, AND COMPOSITIONS CONTAINING SAID WATER SOLUBLE COMPOUNDS | LIBRAGEN (FR) | 2010-07-01 | — | — | WO | claimed |
| CN-101611148-A | Water-soluble phenolic derivatives for cosmetic and therapeutic applications on the skin | LIBRAGEN (FR) | 2009-12-23 | — | — | CN | claimed |
| EP-2027279-A2 | WATER SOLUBLE AND ACTIVABLE PHENOLICS DERIVATIVES WITH DERMOCOSMETIC AND THERAPEUTIC APPLICATIONS AND PROCESS FOR PREPARING SAID DERIVATIVES | Libragen (FR) | 2009-02-25 | — | — | EP | claimed |
| WO-2007144368-A2 | WATER SOLUBLE PHENOLICS DERIVATIVES WITH DERMOCOSMETIC AND THERAPEUTIC APPLICATIONS | LIBRAGEN (FR) | 2007-12-21 | — | — | WO | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| EP-0317453-B1 | MEDICINAL COMPOSITIONS BASED ON FLAVONOIDS AND SAPONINS EXTRACTED FROM CHRYSANTHELLUM, PROCESS FOR THEIR MANUFACTURE AND THERAPEUTICAL USES | IPHYM SA Société Anonyme dite : (FR) | 1993-02-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160106793-A1 | COMPOSITIONS AND METHODS FOR CONTROLING CARBOHYDRATE AND FAT METABOLISM | PLIN3, GYS1, PLIN5 | MEN1 2817/4885KMT2A 2866/4885CDK5 1878/4885 |
| US-20140088030-A1 | WATER SOLUBLE AND ACTIVABLE PHENOLICS DERIVATIVES WITH DERMOCOSMETIC AND THERAPEUTIC APPLICATIONS AND PROCESS FOR PREPARING SAID DERIVATIVES | UGGT1, TYR, G6PD | MEN1 4300/4885KMT2A 1919/4885CDK5 3264/4885 |
| US-10736930-B2 | Compositions and methods for controlling carbohydrate and fat metabolism | CPT1A, PC, PCK1 | MEN1 4051/4885KMT2A 2350/4885CDK5 2603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.